The lactate racemase enzyme (LarA) of Lactobacillus plantarum harbors a (SCS)Ni(II) pincer complex derived from nicotinic acid. Synthesis of the enzyme-bound cofactor requires LarB, LarC, and LarE, which are widely distributed in microorganisms. The functions of the accessory proteins are unknown, but the LarB C terminus resembles aminoimidazole ribonucleotide carboxylase/mutase, LarC binds Ni and could act in Ni delivery or storage, and LarE is a putative ATP-using enzyme of the pyrophosphataseloop superfamily. Here, we show that LarB carboxylates the pyridinium ring of nicotinic acid adenine dinucleotide (NaAD) and cleaves the phosphoanhydride bond to release AMP. The resulting biscarboxylic acid intermediate is transformed into a bisthiocarboxylic acid species by two single-turnover reactions in which sacrificial desulfurization of LarE converts its conserved Cys176 into dehydroalanine. Our results identify a previously unidentified metabolic pathway from NaAD using unprecedented...
The lactate racemase enzyme (LarA) of Lactobacillus plantarum harbors a (SCS)Ni(II) pincer complex derived from nicotinic acid. Synthesis of the enzyme-bound cofactor requires LarB, LarC, and LarE, which are widely distributed in microorganisms. The functions of the accessory proteins are unknown, but the LarB C terminus resembles aminoimidazole ribonucleotide carboxylase/mutase, LarC binds Ni and could act in Ni delivery or storage, and LarE is a putative ATP-using enzyme of the pyrophosphatase-loop superfamily. Here, we show that LarB carboxylates the pyridinium ring of nicotinic acid adenine dinucleotide (NaAD) and cleaves the phosphoanhydride bond to release AMP. The resulting biscarboxylic acid intermediate is transformed into a bisthiocarboxylic acid species by two singleturnover reactions in which sacrificial desulfurization of LarE converts its conserved Cys176 into dehydroalanine. Our results identify a previously unidentified metabolic pathway from NaAD using unprecedented carboxylase and sulfur transferase reactions to form the organic component of the (SCS)Ni(II) pincer cofactor of LarA. In species where larA is absent, this pathway could be used to generate a pincer complex in other enzymes. lactate | racemase | nicotinic acid dinucleotide | sacrificial enzyme L actate racemase (Lar) interconverts D-and L-lactic acid, providing microorganisms with the ability to use or produce both isomers even if only one stereospecific lactate dehydrogenase is present. The enzyme (LarA) harbors a covalently bound Ni pyridinium-3-thioamide-5-thiocarboxylic acid mononucleotide pincer complex featuring a Ni−C bond ( Fig. 1A) (1) . A pincer ligand in organometallic chemistry traditionally consists of a central ring disubstituted with two chelating side arms (2) . The central atom together with the two donor groups on the side arms bind to the metal ion in a planar fashion, providing both structural and thermal stability (2) . Many nickel pincer complexes have been synthesized to stabilize the nickel ion and control its reactivity, some of them exhibiting high catalytic activity (2) . Although pincer complexes are ubiquitous in synthetic chemistry, the LarA cofactor is the first example of a pincer compound identified in the natural world. This cofactor, thought to reversibly capture hydride from the substrate, is synthesized from nicotinic acid by a pathway requiring LarB, LarC, and LarE. LarE is able to activate the LarA apoprotein when isolated from cells also producing LarB and LarC (3) . This result implies that LarE harbors the Ni-containing cofactor before its transfer to LarA. In this study, we describe the biosynthetic pathway leading to the formation of the lactate racemase (SCS)Ni(II) pincer complex starting from the NAD precursor, nicotinic acid adenine dinucleotide (NaAD).
Results
In Vitro LarA Activation. We reconstituted LarA cofactor biosynthesis in vitro by incubating extracts of LarB-containing cells with purified LarC and LarE, along with various additives (SI Appendix, Fig. S1A ). Lar activity was observed for lysates of cells expressing larB (used directly or after filtration to remove proteins) when incubated with ATP (1 mM), MgCl 2 (12 mM) , and the other purified proteins, and the activity was stimulated fivefold by inclusion of CoA (10 mM) (SI Appendix, Fig. S1 A-D). These results are consistent with the requirement of a small molecule produced by LarB being needed for development of Lar activity. To uncover the substrate of LarB, we replaced the LarB-containing lysates in the LarA activation mixture with purified LarB and potential substrates. Because nicotinic acid is a precursor of the Lar cofactor (1) and LarB features partial sequence identity with PurE, an aminoimidazole ribonucleotide (AIR) mutase/carboxylase (4), we tested the possibility that LarB could carboxylate intermediates of the Preiss-Handler pathway from nicotinic acid to NAD (5), namely nicotinic acid mononucleotide (NaMN) and NaAD. Whereas we detected only very low levels of Lar activity when using NaMN, substantial LarA activation was observed for samples incubated with NaAD, and the activity increased with added bicarbonate and Ni 2+ (Fig. 1B) . When the LarB reaction was performed separately from the LarC and LarE reactions, significant Lar activity was only observed when LarB was incubated with NaAD and bicarbonate (Fig. 1C ). ATP and Ni 2+ were not required for the LarB reaction ( Fig. 1C ).
Pyridinium Carboxylation by LarB. To identify the products of LarB, we performed the in vitro LarB reaction with NaAD, MgCl 2 , and NaHCO 3 or NaH 13 CO 3 and compared the samples by liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS). In the absence of LarB, only NaAD was observed, whereas in the presence of LarB we observed the products of Significance Nicotinic acid is a precursor of the ubiquitous cofactors nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP). Previous studies revealed that nicotinic acid is required for lactate racemization, an enzymatic activity that enables microorganisms to produce or use both isomers of lactate. Lactate racemase (Lar) was shown to harbor a nicotinic acid-derived cofactor that coordinates a nickel ion, forming a pincer complex. The biosynthesis of this cofactor requires three accessory proteins: LarB, LarC, and LarE. Here, we describe this biosynthetic pathway by showing that LarB carboxylates and hydrolyzes the NAD precursor nicotinic acid adenine dinucleotide (NaAD) and LarE sacrificially inserts two sulfur atoms into the product of LarB. Finally, LarC inserts the nickel ion to form the mature cofactor.
NaAD hydrolysis, NaMN and AMP ( Fig. 2A ). When we added NaHCO 3 to the LarB reaction, however, a species of m/z = 380.04 appeared, with this species shifting to m/z = 381.04 using NaH 13 CO 3 (Fig. 2B ). Only the LC fractions containing these species were capable of LarA in vitro activation in the presence of LarC and LarE (SI Appendix, Fig. S2 ). These species correspond to the mass of NaMN plus a carboxyl group (C 12 H 15 NO 11 P + : m/z = 380.038; C 11 13 CH 15 NO 11 P + : m/z = 381.045). Fragmentation of these ions yielded products consistent with NaMN being carboxylated on the pyridinium ring (SI Appendix, Fig. S3 ). In particular, the unlabeled and isotopically labeled suspected pyridinium-3,5-biscarboxylic acid mononucleotide (P2CMN) species gave rise to m/z = 168 and 169 positive ion fragments as expected for the corresponding pyridine biscarboxylates (SI Appendix, Fig. S3A ). The dicarboxylated pyridinium ring formed with 13 C can fragment to form NaMN by loss of either the original carboxylate or the 13 C carboxylate. Equivalence of these two species (SI Appendix, Fig. S3B ) is consistent with a symmetric structure, thus indicating the site of carboxylation and confirming that LarB is a NaAD carboxylase-hydrolase-forming P2CMN.
We characterized several properties of LarB-catalyzed P2CMN formation by monitoring the in vitro activation of LarA (SI Appendix, Fig. S4 ). We showed that the K m for NaAD was 13 ± 3 μM (SI Appendix, Fig. S4A ), the K m for MgCl 2 was 0.55 ± 0.18 mM (SI Appendix, Fig. S4B ), and the apparent K m of NaHCO 3 was 33 ± 18 mM (SI Appendix, Fig. S4C ), which are comparable to the values for AIR carboxylation by PurE (6) . We found quite different parameters when examining LarB-catalyzed NaAD turnover by assessing AMP release (SI Appendix, Fig. S5 ). The rate of product release appeared to exhibit hyperbolic behavior (with a K m of 26 ± 15 μM) superimposed on a reaction rate that was linearly dependent on NaAD concentrations (SI Appendix, Fig.  S5A ). The K m for MgCl 2 was 3.9 ± 2.2 mM (SI Appendix, Fig.  S5B ), whereas AMP release was independent of NaHCO 3 concentration (SI Appendix, Fig. S5C ). These results suggest that LarB can hydrolyze NaAD directly or it first forms an adduct with NaAD that releases AMP and reacts with CO 2 to generate P2CMN (SI Appendix, Fig. S5D ).
Sulfur Insertion by LarE. Because the LarA cofactor contains two sulfur atoms (1) ( Fig. 1A) , the role of LarE could be to modify the two carboxylic acids of P2CMN by forming two thiocarboxylic acids. To test this hypothesis, we incubated LarE with P2CMN or 13 C-labeled P2CMN (P2CMN*) obtained through the in vitro reaction of LarB with NaAD and NaHCO 3 or NaH 13 CO 3 , respectively. After incubation, LarE was digested with trypsin, and the solution was analyzed by LC-ESI-MS. We detected species of m/z = 396.02 and m/z = 411.99 when using P2CMN and of m/z = 397.02 and m/z = 413.00 when using P2CMN* (Fig. 2C ). The molecular masses of these species are consistent with pyridinium-3carboxy-5-thiocarboxylic acid mononucleotide (PCTMN) and pyridinium-3,5-bisthiocarboxylic acid mononucleotide (P2TMN) (C 12 H 15 NO 10 SP + : m/z = 396.015 and C 12 H 15 NO 9 S 2 P + : m/z = 411.993). The two putative PCTMN species (unlabeled and labeled, respectively) gave rise to tandem MS (MS/MS) species (m/z = 184 and 185) that were expected for the corresponding pyridine-3-carboxylate-5-thiocarboxylate fragments (SI Appendix, Fig. S6 ). The two putative P2TMN species (unlabeled and labeled, respectively) similarly gave rise to MS/MS species (m/z = 200 and 201) that were expected for the corresponding pyridine bisthiocarboxylate fragments (SI Appendix, Fig. S7 ). The presence of m/z = 183 and 184 species in the positive-ionization mode and of m/z = 333, 334, 393, and 394 species in the negative ionization mode indicates the presence of pyridinium-3carboxamide-5-thiocarboxylic acid mononucleotide (SI Appendix, Fig. S6 ), which probably arose as a product of the nucleophilic attack of P2TMN by the ammonia present in solution.
Furthermore, the putative PCTMN and P2TMN species led to m/z = 334 and 350 negative ion fragments, respectively, arising from loss of COS, which is consistent with sulfur insertion into the carboxylic acid groups of P2CMN (SI Appendix, Figs. S6 and S7), confirming the identity of these species and showing that LarE is responsible for sulfurization of P2CMN into P2TMN. Fig. S9 ). In particular, a modified peptide of 1,659.51 Da was detected in both negative and positive ion ESI-MS modes that matches that expected for the mass of the peptide corresponding to residues 173-181 (894.41 Da) plus CoA (767.12 Da) less two protons (2.02 Da). Furthermore, several MS/MS products were consistent with this assignment, including some possessing a persulfide, as expected for fragmentation of a mixed disulfide (7) (SI Appendix, Fig. S9 ). We suggest the LarE-CoA disulfide is an offpathway species likely to be formed by reaction of the nucleophilic LarE cysteinyl group with CoA disulfide formed in the aerobic Fig. S8 ). The intermediate species increased by 1 mass unit when using NaH 13 CO 3 in the LarB reaction solution, and the mass was consistent with LarE being linked to P2CMN (SI Appendix, Fig. S8 ). Neither the intermediate nor the final LarE species was observed in the absence of ATP (SI Appendix, Fig. S8 ), indicating that ATP is required for these transformations. The final LarE species, with a mass 34 Da smaller than the free protein, was shown to possess a peptide corresponding to residues 173-181 but with Cys replaced by dehydroalanine (Dha) ( Fig. 3B and SI Appendix, Fig. S10 ). The loss of sulfur from Cys176 accompanies the conversion of P2CMN to P2TMN, consistent with LarE serving as a substrate by offering its cysteinyl group as the sulfur donor. Even though much of the protein begins as the CoA disulfide, all LarE is converted in this reaction because of the presence of excess CoA in the mixture (i.e.,
LarE purified from cells expressing the entire larA-E operon was mostly in the desulfurized form (SI Appendix, Fig. S11A ), suggesting that the LarE cysteine is not regenerated in vivo. These results lead us to propose a reaction mechanism in which a carboxyl group of P2CMN is first adenylylated by ATP [similar to the activation of NaMN by the LarE homolog nicotinamide mononucleotide synthetase (8) observation of a near 2:1 LarE:LarA ratio for optimal Lar activity (SI Appendix, Fig. S11C ).
LarC-Mediated Nickel Insertion and Transfer to LarA. Further steps in the generation of Lar activity include nickel insertion into P2TMN, a process that must use LarC (which purifies with bound Ni) because nickel alone is not inserted (Fig. 4A ), and transfer of the mature cofactor into the LarA apoprotein (3). We observed a time-dependent increase in Lar activity when the cofactor was transferred into Lactobacillus plantarum LarA apoprotein, requiring 90 min to reach maximal activity when sulfite, known to protect LarA from oxidation (1), was present ( Fig. 4B ). Our analysis of the in vitro-activated LarA proteins by LC-ESI-MS revealed the expected mass shift corresponding to the addition of the cofactor to LarA (SI Appendix, Fig. S12A ). LC-ESI-MS and LC-ESI-MS/MS analyses of in vitro-activated LarA digested with trypsin confirmed the presence of K 184 SVLPGIASYK peptide covalently linked to the (SCS)Ni(II) cofactor (SI Appendix, Figs. S12B and S13), as previously described (1) . The mass of this peptide was shifted by 1 Da when using LarB-generated P2CMN* in the activation mixture (SI Appendix, Figs. S12B and S13), demonstrating that the cofactor in LarA is derived from P2TMN.
Discussion
We propose a scheme for the biosynthesis of active L. plantarum LarA in which LarB converts NaAD into P2CMN, LarE incorporates two sulfur atoms to yield P2TMN, LarC donates Ni, and the mature cofactor becomes covalently attached to LarA apoprotein (Fig. 5) . The LarB-dependent carboxylation reaction requires bicarbonate/CO 2 (Fig. 1C ) and somewhat resembles AIR carboxylation by the LarB homolog PurE (10); however, biological carboxylation of a pyridinium ring was previously unknown. To perform this chemistry, a nucleophilic amino acid of LarB may attack the pyridinium ring of NaAD to neutralize the positive charge and allow for direct attack of the ring C5 on CO 2 . ATP is not required for the LarB reaction (Fig. 1C) , so ATPdependent activation of bicarbonate does not take place. An alternative hypothesis is that the LarB-catalyzed cleavage of the phosphoanhydride bond of NaAD may activate bicarbonate by formation of carboxy-AMP. This hypothesis would explain why NaMN is not a substrate of LarB (Fig. 1C) .
LarE possesses multiple functions: activation of P2CMN by adenylylation, covalent linkage of the protein to P2CMN, sacrificial loss of its Cys176 sulfur atom to form the thioacid of P2CMN, and then repeating the set of reactions with a second LarE protomer to form P2TMN. Although we have not yet detected adenylylated P2CMN or the LarE-PCTMN derivative, we did observe the LarE-P2CMN adduct and demonstrated Dha in the product LarE. Sulfur-containing cofactors are typically synthesized by using the sulfur atom of free cysteine through the action of a persulfide-forming cysteine desulfurase (11); however, direct sulfur donation from a protein cysteinyl group, also generating a Dha residue, has been reported in the case of thiamine thiazole synthase of Saccharomyces cerevisiae, THI4p (12) . Whereas a single molecule of THI4p is used to insert the lone sulfur atom 
Materials and Methods
Biological Materials and Growth Conditions. Bacterial strains and plasmids used in the present study are listed in SI Appendix, Table S1 . We grew Lactococcus lactis in M17 broth supplemented with 0.5% glucose at 28°C. NiSO 4 (1 mM) was added to cultures expressing pGIR051, and chloramphenicol (10 mg·L −1 ) was provided when expressing plasmids derived from pNZ8048. For the induction of genes under control of the nisA expression signals, nisin A (Sigma-Aldrich) was added during the early exponential phase (OD 600 = 0.3-0.4) at a concentration of 1 μg·L −1 , and the cells were collected after 4 h. Escherichia coli DH10B was grown with agitation (200 rpm) at 37°C in LB containing erythromycin (200 mg·L −1 ).
DNA Techniques. General molecular biology techniques were performed according to standard protocols (13) . Transformation of E. coli and L. lactis was performed by electrotransformation (14, 15) . PCR amplifications used Phusion high-fidelity DNA polymerase (New England Biolabs). The primers used in this study were purchased from IDT and are listed in SI Appendix, Table S1 . Plasmid pGIR026, derived from pGIZ660 (4), bears a translational fusion of larB and DNA encoding the StrepII tag for expression in E. coli. pGIZ660 was PCR-amplified with the primers BT_A and BT_B, digested with NheI, and self-ligated, generating a 30-bp in-frame insertion of a fragment encoding the StrepII tag at the C terminus of LarB. The ligation mixture was treated with DpnI before transformation into E. coli to digest the original pGIZ660 plasmid template. Plasmids bearing variants of larE for expression in L. lactis were derived from pGIR072 (3) (i.e., pGIR072M1-M2) and provided the two variant forms (D30A, C176A) of LarE. For each construction, pGIR072 was first methylated by Dam methylase using S-adenosyl methionine (New England Biolabs), and PCR amplification was performed to obtain a fragment comprising the mutated plasmid. The PCR product was digested with DpnI before transformation in L. lactis according to the Quickchange mutagenesis protocol (16) . The plasmid sequences were confirmed by sequencing with primer UP_PNZ8048′.
Cell Lysate Preparation. A total of 1.5 L of L. lactis cultures expressing pNZ8048 (empty vector) or pGIR022 (encoding LarB) were collected and the pellets were washed twice in 100 mM Tris·HCl at pH 7.5 (buffer T), resuspended in 15 mL of buffer T with 15 g·L −1 of lysozyme, incubated 30 min at 37°C, and cooled 10 min on ice. This treatment was followed by sonication at maximum amplitude (Branson Sonifier 450) using two series of 10 one-second pulses with an intervening 1-min pause on ice. Clear supernatants were obtained after centrifugation at 12,000 × g for 25 min at 4°C. For obtaining deproteinized cell lysates, the supernatants were placed into an Amicon Ultra-15 centrifugal filter unit (10-kDa cutoff; Merck Millipore) and spun, and the flow-through fraction was collected.
Protein Purification. LarA from L. plantarum (LarA Lp ) or Thermoanaerobacterium thermosaccharolyticum (LarA Tt ), LarC, and LarE were purified from 1.5 L of the appropriate L. lactis cultures (containing plasmids that are listed in SI Appendix, Table S1 ), which were collected by centrifugation (5,000 × g for 10 min) and washed twice with 50 mL of 100 mM Tris·HCl (pH 7.5) buffer containing 150 mM NaCl (buffer W). Cells were resuspended in 15 mL of W buffer and transferred by 0.5-mL aliquots into 0.5-mL suspensions of glass beads (≤106 μm; Sigma) in W buffer using 2-mL microtubes. Lysis was accomplished by using a Mini-Beadbeater-16 (BioSpec Products) twice for 1-min periods, with 2 min of cooling on ice between the runs. After lysis, the soluble fractions were collected by centrifugation at 20,000 × g for 15 min at 4°C. Affinity chromatography was performed with gravity-flow Strep-Tactin Superflow highcapacity columns of 1.5 mL, as described (17), with buffer W. For purification of LarE in the presence or CoA, 0.5 mM CoA was added to all buffers. Protein concentrations were measured by Bradford assay (18) . LarB was purified from 1.5 L of overnight E. coli culture expressing pGIR026. The cells were collected, and the pellet was washed twice in buffer W, resuspended in buffer W with 1 g·L −1 lysozyme, incubated for 30 min at 37°C, and cooled for 10 min on ice. This treatment was followed by sonication at maximum amplitude (Branson Sonifier 450) using three series of 10 one-second pulses with intervening 2-min pauses on ice. Clear supernatant was obtained after centrifugation at 12,000 × g for 30 min at 4°C. Affinity chromatography was performed with gravity-flow Strep-Tactin Superflow high-capacity columns of 1.5 mL, as described (17), with buffer W.
In Vitro Activation of LarA by Lysates from LarB-Containing Cells or by Purified LarB, LarC, and LarE. We incubated a mixture of LarE (5 μM), LarC (5 μM), ATP (5 mM), MgCl 2 (20 mM), and CoA (1 mM) in Tris·HCl buffer (100 mM; pH 8) with 10 μL of lysates from lar-free cells or cells expressing larB in a final volume of 20 μL. After 1 h of incubation at room temperature (RT), 5 μL of the assay mixture was diluted into 45 μL of L-lactate (45 mM) supplemented with LarA Tt apoprotein (0.8 μM) in Hepes buffer (100 mM; pH 7) . The reaction was incubated for 5 min at 50°C and then stopped by heat treatment at 90°C. The resulting D-lactate concentration was measured by enzymatic lactate oxidation to pyruvate using a D-lactic acid/L-lactic acid commercial test (Megazyme), as previously described (3). The NADH absorbance was monitored at 340 nm with a SpectraMax M5 (Molecular Devices) (SI Appendix, Fig. S1 ). For optimization of MgCl 2 , ATP, and CoA concentrations, the concentration of one component was varied with the other components held static. For analyses of LC fractions, the lysates were replaced by LarB reaction products (control) or by LC-separated fractions of LarB reaction products (SI Appendix, Fig. S2 ).
To examine the purified LarB reaction, we replaced the lysate in the previous experiment with LarB (1 μM) and incubated it with NaMN (0.5 mM) or NaAD (0.5 mM) along with NaHCO 3 (10 mM) and NiCl 2 (0.1 mM). After 2 h of incubation at RT, L-lactate (45 mM) supplemented with LarA Tt apoprotein (0.8 μM) was added, and Lar activity was measured as described above in Fig.  1B . For analyses of LarE variants, LarE was replaced by D30A LarE and C176A LarE (SI Appendix, Fig. S11B ). For analyses of LarC activity, LarC was added at different concentrations (Fig. 4A ). For analysis of the separate LarB carboxylation reaction, LarB (0.5 μM) was mixed with NaMN (0.2 mM), NaAD (0.2 mM), NaHCO 3 (100 mM), ATP (5 mM), NiCl 2 (0.1 mM), and MgCl 2 (4 mM) in Tris·HCl buffer (100 mM; pH 8) and incubated 10 min at RT, and the reaction stopped by heat treatment at 90°C. The reaction solutions were used instead of the cell lysate for in vitro activation of LarA Tt , as described above in Fig. 1C . For optimization of the LarB carboxylation reaction, LarB (0.5 μM) was mixed with varied concentrations of one component with the other components held static [NaAD (0.2 mM), NaHCO 3 (50 mM), and MgCl 2 (4 mM) in Tris·HCl buffer (100 mM; pH 8)], incubated 5 min at RT, and the reaction was stopped by heat treatment at 90°C. The reaction solutions were used for in vitro activation of LarA Tt , as described above in SI Appendix, Fig. S4 . For measurement of the concentrations of AMP released from NaAD, the AMP-Glo Assay (Promega) was used (SI Appendix, Fig. S5 ). For studying the properties of phosphoanhydride cleavage by LarB, the NaAD, NaHCO 3 , and MgCl 2 concentrations were modified as indicated.
LC-ESI-MS of Small Molecules. For LC-ESI-MS analysis of the LarB product, we incubated LarB (5 μM), NaAD (0.5 mM), MgCl 2 (4 mM), and NaHCO 3 (10 mM) or NaH 13 CO 3 (10 mM) in Tris·HCl buffer (100 mM; pH 8) in a final volume of 250 μL. After overnight incubation, samples were analyzed directly by LC-ESI-MS ( Fig. 2 A and B) . For analysis of the LarE product (Fig. 2C) , we incubated the product of the previous LarB reaction with LarE (15 μM), ATP (5 mM), MgCl 2 (20 mM), and CoA (1 mM) in a final volume of 250 μL, concentrated the sample after a 30-min reaction at RT to 50 μL in an Amicon Ultra-0.5 (10 kDa cutoff) centrifugal filter (Merck Millipore), and washed the product three times with ammonium bicarbonate (AB) buffer (100 mM; pH 8). Trypsin (5 μg) was added, the protein was digested for 2 h at 37°C, and samples were analyzed by LC-ESI-MS. For analysis of small molecules, 10-μL aliquots were injected into a Waters Acquity ultra-performance LC system coupled to a Waters Xevo G2-S quadruple time-of-flight mass spectrometer. Separations were performed using a bridged ethylene hybrid (BEH) C18 (100 mm × 2.1 mm; 1.7-μm particle size) column with an isocratic flow of 10 mM AB buffer (pH 8) at 30°C. The run time for each sample was 15 min. MS/MS spectra (SI Appendix, Figs. S6 and S7) were generated by using argon as collision gas and a collision cell potential 10 V.
LC-ESI-MS of Proteins and Peptides. For analysis of the different forms of LarE (Fig. 3A and SI Appendix, Figs. S8 and S11) , LarE (10 μM) was incubated with ATP (5 mM), MgCl 2 (20 mM), and 50% volume of LarB reaction (as described for LC-ESI-MS of LarB product) for 0, 15, 30, and 45 min and analyzed by LC-ESI-MS; 10-μL aliquots were injected into the UPLC system coupled to the QTof mass spectrometer. Separations were performed on a BetaBasic CN (10 mm × 1 mm; 5-μm particle size) column with an aqueous phase of 0.1% formic acid and using a gradient of increasing acetonitrile at 30°C. The run time for each sample was 15 min. The masses were calculated from the ESI-MS spectrum using the advanced maximum entropy (MaxEnt)-based procedure included in the Micromass MassLynx software package.
For LC-ESI-MS analysis of peptides ( Fig. 3B and SI Appendix, Figs. S9 and S10), LarE (100 μg) was digested with trypsin (5 μg) for 2 h at 37°C; 10-μL aliquots were injected into the UPLC system coupled to the QTof mass spectrometer. Separations were performed on a BEH C18 (100 mm × 2.1 mm; 1.7-μm particle size) column with an aqueous phase of 0.1% formic acid and a gradient of increasing acetonitrile at 40°C. The run time for each sample was 15 min. MS/MS spectra were generated by using argon as the collision gas and a collision cell potential of 40 V. (Fig. 4B) , we used LarA Lp in Hepes buffer (400 mM; pH 7), and Na 2 SO 3 (10 μM) was added where indicated. The assay was incubated for 0, 30, 60, 90, and 120 min at RT, and 3 μL was diluted into 47 μL of 45 mM L-lactate in Mes (100 mM; pH 6) buffer. The reaction was incubated for 5 min at 35°C and stopped by heat treatment at 90°C, and the Lar activity was measured as described above. For LC-ESI-MS analysis, 250 μL of the LarA in vitro activation mixture (incubated for 90 min at RT) was directly analyzed (SI Appendix, Fig. S12A ) or washed three times with AB buffer (100 mM; pH 8), trypsin-digested as described previously (1) , and analyzed (SI Appendix, Figs. S12B and S13). 
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